ArticleMedical science monitor : international medical journal of experimental and clinical research2026
Impact of Dual Thyroid and Prostate Cancer Diagnosis on Patient Survival: Insights From a Large Cohort Study.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Thyroid cancer (TC) and prostate cancer (PC) are common endocrine-related malignancies. Given the growing population of patients diagnosed with both cancers, their prognosis requires clarification. This study aimed to compare mortality between patients with both TC and PC and those with TC or PC alone. MATERIAL AND METHODS In this retrospective cohort study, data were derived from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2021), including 2334 men with records of both TC and PC (TC+PC group), 37 979 men with only TC (TC-only group), and 876 838 men with only PC (PC-only group). Cox proportional hazards regression and competing risk models were used to analyze patient mortality, supplemented by a propensity score-matching sensitivity analysis. RESULTS Cox regression modeling showed that survival among patients with TC and a history of PC was better than among patients with TC and no history of PC. Hazard ratios (HRs) for all-cause mortality and TC-specific mortality, compared with the TC-only group, were 0.78 (95% confidence interval [CI], 0.71-0.87) and 0.58 (95% CI, 0.47-0.72), respectively. Similarly, patients with PC and a history of TC showed reduced all-cause mortality (HR=0.83, 95% CI, 0.75-0.91) and PC-specific mortality (HR=0.62, 95% CI, 0.50-0.78). Superior survival in the TC+PC group was confirmed by competing risk models and propensity score-matching analysis. CONCLUSIONS This study demonstrates a mutually favorable survival association between TC and PC, indicating that a history of either cancer warrants consideration in prognostic evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.